Search Results - "Sukel, Myrthe P. P."

Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives: Results from a large population-based follow-up study by Ruiter, Rikje, Visser, Loes E, van Herk-Sukel, Myrthe P.P, Coebergh, Jan-Willem W, Haak, Harm R, Geelhoed-Duijvestijn, Petronella H, Straus, Sabine M.J.M, Herings, Ron M.C, Stricker, Bruno H.Ch

“…OBJECTIVE: Numerous studies have suggested a decreased risk of cancer in patients with diabetes on metformin. Because different comparison groups were used,…”
Get full text

Half of breast cancer patients discontinue tamoxifen and any endocrine treatment before the end of the recommended treatment period of 5 years: a population-based analysis by van Herk-Sukel, Myrthe P. P, van de Poll-Franse, Lonneke V, Voogd, Adri C, Nieuwenhuijzen, Grard A. P, Coebergh, Jan Willem W, Herings, Ron M. C

“…Observational studies on long-term endocrine treatment among breast cancer patients have presented discontinuation rates on tamoxifen, but lack information on…”
Get full text

Patterns of metachronous metastases after curative treatment of colorectal cancer by van Gestel, Yvette R.B.M, de Hingh, Ignace H.J.T, van Herk-Sukel, Myrthe P.P, van Erning, Felice N, Beerepoot, Laurens V, Wijsman, Jan H, Slooter, Gerrit D, Rutten, Harm J.T, Creemers, Geert-Jan M, Lemmens, Valery E.P.P

“…Highlights • One fifth of operated colorectal cancer patients will develop metachronous metastases. • Colon and rectal cancer patients have different patterns…”
Get full text

Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study by Weberpals, Janick, Jansen, Lina, Haefeli, Walter E., Hoffmeister, Michael, Wolkewitz, Martin, Herk-Sukel, Myrthe P. P. van, Vissers, Pauline A. J., Brenner, Hermann

“…Beta-blockers have been associated with decreased cancer mortality. However, evidence for lung cancer is sparse and reported beneficial effects might be based…”
Get full text

Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer by Reimers, Marlies S, Bastiaannet, Esther, Langley, Ruth E, van Eijk, Ronald, van Vlierberghe, Ronald L P, Lemmens, Valery E P, van Herk-Sukel, Myrthe P P, van Wezel, Tom, Fodde, Riccardo, Kuppen, Peter J K, Morreau, Hans, van de Velde, Cornelis J H, Liefers, Gerrit Jan

“…Use of aspirin (which inhibits platelet function) after a colon cancer diagnosis is associated with improved overall survival. Identifying predictive…”
Get more information

A population‐based linked cohort of cancer and primary care data: A new source to study the management of cancer in primary care by Kuiper, Josephina G., Herk‐Sukel, Myrthe P. P., Lemmens, Valery E. P. P., Kuipers, Ernst J., Herings, Ron M. C.

“…Objective Insight into the management of cancer in the primary care setting is pivotal to improve early recognition and survival of cancer patients. Therefore,…”
Get full text

Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts by Cardwell, Chris R, Pottegård, Anton, Vaes, Evelien, Garmo, Hans, Murray, Liam J, Brown, Chris, Vissers, Pauline A J, O'Rorke, Michael, Visvanathan, Kala, Cronin-Fenton, Deirdre, De Schutter, Harlinde, Lambe, Mats, Powe, Des G, van Herk-Sukel, Myrthe P P, Gavin, Anna, Friis, Søren, Sharp, Linda, Bennett, Kathleen

“…Preclinical studies have demonstrated that propranolol inhibits several pathways involved in breast cancer progression and metastasis. We investigated whether…”
Get full text

Pharmaceutically treated anxiety but not depression prior to cancer diagnosis predicts the onset of cardiovascular disease among breast cancer survivors by Schoormans, Dounya, van de Poll-Franse, Lonneke, Vissers, Pauline, van Herk-Sukel, Myrthe P. P., Pedersen, Susanne S., Rottmann, Nina, Horsbøl, Trine, Dalton, Susanne, Denollet, Johan

“…Purpose To examine the associations between pharmaceutically treated anxiety and depression present in the year prior to breast cancer diagnosis and the risk…”
Get full text

Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes by Zanders, Marjolein M. J., Haak, Harm R., van Herk-Sukel, Myrthe P. P., van de Poll-Franse, Lonneke V., Johnson, Jeffrey A.

“…Aims/hypothesis Adherence to glucose-lowering drug (GLD) treatment regimens is crucial for metabolic control and improving prognosis. Because a diagnosis of…”
Get full text

Incidence of cardiovascular disease up to 13 year after cancer diagnosis: A matched cohort study among 32 757 cancer survivors by Schoormans, Dounya, Vissers, Pauline A. J., Herk‐Sukel, Myrthe P. P., Denollet, Johan, Pedersen, Susanne S., Dalton, Susanne O., Rottmann, Nina, Poll‐Franse, Lonneke

“…We examined the incidence of cardiovascular disease (CVD) among 32 757 cancer survivors and age‐, gender‐, and geographically matched cancer‐free controls…”
Get full text

The Influence of BRAF and KRAS Mutation Status on the Association between Aspirin Use and Survival after Colon Cancer Diagnosis by Frouws, Martine A, Reimers, Marlies S, Swets, Marloes, Bastiaannet, Esther, Prinse, Bianca, van Eijk, Ronald, Lemmens, Valery E P P, van Herk-Sukel, Myrthe P P, van Wezel, Tom, Kuppen, Peter J K, Morreau, Hans, van de Velde, Cornelis J H, Liefers, Gerrit-Jan

“…Use of aspirin after diagnosis of colon cancer has been associated with improved survival. Identification of cancer subtypes that respond to aspirin treatment…”
Get full text

Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen by Binkhorst, Lisette, Mathijssen, Ron H. J., van Herk-Sukel, Myrthe P. P., Bannink, Marjolein, Jager, Agnes, Wiemer, Erik A. C., van Gelder, Teun

“…Tamoxifen is a largely inactive pro-drug, requiring metabolism into its most important metabolite endoxifen. Since the cytochrome P450 (CYP) 2D6 enzyme is…”
Get full text

New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage System by van Herk-Sukel, Myrthe P.P, van de Poll-Franse, Lonneke V, Lemmens, Valery E.P.P, Vreugdenhil, Gerard, Pruijt, Johannes F.M, Coebergh, Jan Willem W, Herings, Ron M.C

“…Abstract Background Insight into co-morbidity and treatment effects is pivotal to improve quality of care for cancer patients. Objectives To determine whether…”
Get full text

Effect of Concomitant CYP2D6 Inhibitor Use and Tamoxifen Adherence on Breast Cancer Recurrence in Early-Stage Breast Cancer by DEZENTJE, Vincent O, VAN BLIJDERVEEN, Nico J. C, GELDERBLOM, Hans, PUTTER, Hein, VAN HERK-SUKEL, Myrthe P. P, CASPARIE, Mariel K, EGBERTS, Antoine C. G, NORTIER, Johan W. R, GUCHELAAR, Henk-Jan

“…The use of cytochrome P450 2D6-inhibiting drugs (CYP2D6 inhibitors) during tamoxifen treatment leads to a decrease in plasma concentration of endoxifen, the…”
Get full text

Aspirin Use After Diagnosis Improves Survival in Older Adults with Colon Cancer: A Retrospective Cohort Study by Reimers, Marlies S., Bastiaannet, Esther, van Herk-Sukel, Myrthe P. P., Lemmens, Valery E. P., van den Broek, Colette B. M., van de Velde, Cornelis J. H., de Craen, Anton J. M., Liefers, Gerrit Jan

“…Objectives To assess survival in relation to aspirin use after diagnosis in older adults with colon cancer. Design Subgroup analysis of a previously published…”
Get full text

Incident cancer risk after the start of aspirin use: Results from a Dutch population‐based cohort study of low dose aspirin users by Hollestein, Loes M., Herk‐Sukel, Myrthe P.P., Ruiter, Rikje, Vries, Esther, Mathijssen, Ron H.J., Wiemer, Erik A.C., Stijnen, Theo, Coebergh, Jan‐Willem W., Lemmens, Valery E.P.P., Herings, Ron M.C., Stricker, Bruno H.C., Nijsten, Tamar

“…Observational and intervention studies suggest that low dose aspirin use may prevent cancer. The objective of this study was to investigate the protective…”
Get full text

Type 2 Diabetes, but Not Insulin (Analog) Treatment, Is Associated With More Advanced Stages of Breast Cancer: A National Linkage of Cancer and Pharmacy Registries by Overbeek, Jetty A, van Herk-Sukel, Myrthe P P, Vissers, Pauline A J, van der Heijden, Amber A W A, Bronsveld, Heleen K, Herings, Ron M C, Schmidt, Marjanka K, Nijpels, Giel

“…To investigate whether women with type 2 diabetes (T2D) develop a more advanced stage of breast cancer and whether treatment with insulin (analogs) is…”
Get full text

Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008 by Timmers, Lonneke, Beckeringh, Jan Jacob, van Herk-Sukel, Myrthe P. P., Boven, Epie, Hugtenburg, Jacqueline G.

“…ABSTRACT Purpose In recent years, the number of oral anticancer agents has increased substantially. Although these agents have quickly been incorporated in the…”
Get full text

Record linkage for pharmacoepidemiological studies in cancer patients by van Herk-Sukel, Myrthe P. P., Lemmens, Valery E. P. P., van de Poll-Franse, Lonneke V., Herings, Ron M. C., Coebergh, Jan Willem W.

“…ABSTRACT Background An increasing need has developed for the post‐approval surveillance of (new) anti‐cancer drugs by means of pharmacoepidemiology and…”
Get full text

Statin use and its effect on all‐cause mortality of melanoma patients: a population‐based Dutch cohort study by Livingstone, Elisabeth, Hollestein, Loes M., Herk‐Sukel, Myrthe P. P., Poll‐Franse, Lonneke, Joosse, Arjen, Schilling, Bastian, Nijsten, Tamar, Schadendorf, Dirk, Vries, Esther

“…Preclinical data showed anticancer effects of statins in melanoma, but meta‐analyses could not demonstrate a reduced melanoma incidence in statin users. Rather…”
Get full text